August 2018 FDA Recall Tyvaso by United Therapeutics Corp.
D-1188-2018 - Defective Delivery System

This Class III drug recall was voluntarily initiated by United Therapeutics Corp. on August 14, 2018 for the product Tyvaso. The FDA reported the reason for recall as defective delivery system. The product was distributed in IL, PA and the recall is currently terminated.

Recall Number: D-1188-2018

Reason for Recall
Defective Delivery System: Water ingress through the lower water cup sensor of the device.
Initiated
08-14-2018
Reported
09-19-2018
Quantity
2801 devices

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
United Therapeutics Corp.
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709

Batch or Lot Expiration Information

Lot# Lot number a) 2101503, 2101507, 2101523, 2101532, 2101533, EXP 07/31/2019; 2101557, EXP 11/30/2019 b)
Lot# 2101504, EXP 4/24/2021; 2101509, 2101522, EXP 5/8/2021; 2101531, EXP 5/15/2021; 2101534, EXP 6/10/2021; 2101543, EXP 6/14/2021; 2101558, EXP 7/26/2021